GLP-1 Antibody (033-10) is a mouse monoclonal IgG2a antibody that detects glucagon-like peptide-1 (GLP-1) in human samples through enzyme-linked immunosorbent assay (ELISA). GLP-1 plays a crucial role in glucose metabolism and appetite regulation, functioning as an incretin hormone that enhances insulin secretion in response to meals while simultaneously inhibiting glucagon release, thereby lowering blood sugar levels. GLP-1 is primarily produced in the intestinal L-cells and is vital for maintaining glucose homeostasis and promoting satiety, making GLP-1 a significant target for diabetes and obesity research. Additionally, GLP-1 undergoes post-translational modifications, including cleavage by the enzyme dipeptidyl peptidase-4 (DPP-4), which inactivates the hormone and limits therapeutic potential. Understanding these modifications is essential for developing GLP-1-based therapies, as modifications can influence the duration of action and efficacy of GLP-1 receptor agonists used in clinical settings. Anti-GLP-1 antibody (033-10) is an invaluable tool for researchers investigating the intricate roles of GLP-1 in metabolic disorders.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GLP-1 Antibody (033-10) | sc-65389 | 100 µg/ml | $316.00 |